After $9.9 billion sale, Envision turns its attention back to insurance dispute

Envision Healthcare CEO Chris Holden says his company will move forward with its strategic plan now that it ’s been sold to a New York-based investment firm for $9.9 billion — including resolving issues with insurance companies like UnitedHealthcare.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 13, 2018 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news